GLP-1 Therapy for Type 2 Diabetes & Weight Loss
This dual burden is not just epidemiological; it\'s economic and clinical. Excess adiposity and impaired glucose metabolism are intricately linked, increasing the risk of cardiovascular disease, renal dysfunction, and premature mortality. As standard interventions such as diet, lifestyle modification, and metformin therapy yield suboptimal adherence or limited long-term outcomes in certain patient segments, GLP-1 receptor agonists have emerged as pivotal agents in altering the treatment paradigm.